πŸ‡ΊπŸ‡Έ FDA
Patent

US 12257277

Adeno-associated virus formulations

granted A61KA61K31/195A61K35/76

Quick answer

US patent 12257277 (Adeno-associated virus formulations) held by Takeda Pharmaceutical Company Limited expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/195, A61K35/76, A61K47/02, A61K47/18